Idiopathic intracranial hypertension (IIH) is a syndrome of increased intracranial pressure and presents as an intractable headache, vomiting, and ophthalmologic manifestations. We herein report the case of a young girl who presented with bilateral abducens nerve palsy due to IIH as the onset of systemic lupus erythematosus (SLE). The patient was successfully treated with corticosteroid therapy. Our case lacked the typical symptoms of IIH, such as headache or nausea; therefore, it is necessary to carefully determine the cause of bilateral abducens nerve palsies. The development of IIH in SLE patients is a rare occurrence, but this manifestation should not be overlooked.
Introduction
Idiopathic intracranial hypertension (IIH) is characterized by symptoms of elevated intracranial pressure, elevated cerebrospinal fluid (CSF) pressure, normal CSF content, and normal neuroimaging studies (1) . Although IIH generally emerges in overweight women of childbearing age (2) , it is known that IIH is also induced by medication, infection, or medical disorders such as endocrinological disease, vitamin deficiency, and autoimmune diseases (3) . We herein present a case of IIH as the onset of systemic lupus erythematosus (SLE) with bilateral abducens nerve palsy without headache or nausea. A 14- year-old girl was admitted to a local hospital with a high fever that had lasted for a few days in March 2010. She had been treated for asthma and allergic rhinitis, and she had not suffered from any asthma attacks for several years. At the first visit, the patient was tentatively diagnosed with a viral infection, and her fever subsided with palliative care.
Case Report
However, the subsequent laboratory data revealed leukopenia, proteinuria, microscopic hematuria, positive antinuclear antibodies (ANA) and an increased serum level of antidouble-stranded DNA (dsDNA) antibodies. Ten days after this admission, the patient became aware of diplopia and was referred to our hospital for a further examination for ophthalmological abnormalities. She was not receiving any medications, such as corticosteroids or antibiotics, or any supplements, including vitamin A, which are known to be risk factors for IIH. She did not complain of either headache or nausea. Upon changing hospitals, an examination of her vital signs demonstrated no abnormalities except for slight
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diastolic hypertension (125/92 mmHg). Her height was 155.7 cm, her body weight was 54.3 kg and her body mass index was 22.4 kg/m 2 , indicating that she was not obese. She had a malar rash and palmar erythema, and her palpebral conjunctiva was anemic. She was alert with no signs of meningeal irritation. On neurological examination, the abduction of both eyes was insufficient (left; 3/5, right 4/5) and became exacerbated while she was looking to the left side. Her pupils were symmetrical and reactive to light. She had no other cranial neuropathy, no motor or sensory neuron disorders, and no pathological reflexes.
Ophthalmological examinations demonstrated papilledema during both distal and proximal sight, indicative of bilateral incomplete abducens nerve palsy with papilledema ( Figure a ). There were no accommodation disturbances, and her visual field and visual activity (vision without correction: right: 0.3, left: 0.4; vision with correction: right: 1.5, left: 1.2) were normal. A critical flicker frequency test revealed normal activity of the optic nerves. The laboratory findings showed pancytopenia with a high titer of anti-dsDNA antibodies and hypocomplementemia. The anti-cardiolipin antibodies were slightly positive, whereas lupus anticoagulant and anti-β2GPI antibodies were negative (Table) . The prothrombin time (11.6 sec) and activated partial thromboplastin time (27.5 sec) were normal. The D-dimer level was slightly elevated (2.5>0.9 μg/mL); however, there were no signs of thrombotic or hemorrhagic activity. A urinalysis revealed proteinuria and hematuria with active cellular casts. The viral specific antibody profile revealed no evidence of active viral infection (Table) .
Brain magnetic resonance imaging (MRI), MR angiography and plain computed tomography (CT) showed no findings of ischemia, thrombosis or vasculitis (Figure c, d) , while a CSF analysis revealed an extremely high opening pressure (320 mmH2O) with normal CSF indices (Table) . There was no evidence of malignancy (cytology class 2) or infection. These findings indicated that the patient had IIH that caused bilateral incomplete abducens nerve palsy with papilledema. The levels of interleukin (IL)-6 were also increased (at 6.4 pg/mL) as was the ribosome P IgG antibody titer (at 3.0 U; normal <1.0 U) in the CSF. A diagnosis of definitive SLE was promptly made according to the American College of Rheumatology (ACR) SLE classification criteria on hospital day 1 (4). The slight increases in the levels of IL-6 and ribosome P IgG antibodies in the CSF were thought to be due to neuropsychiatric SLE. Lupus nephritis was also subsequently diagnosed and histologically classified as International Society of Nephrology/Renal Pathology Society (ISN/RPS) class III (A/C). Intravenous methylprednisolone pulse therapy (500 mg/ day) was immediately administered for three days, followed by oral treatment with 60 mg of prednisolone daily. Monthly intravenous cyclophosphamide pulse (IVCY) at a dose of 500 mg was concomitantly administered six times.
The pancytopenia recovered the day after the first treatment with methylprednisolone pulse therapy (WBC: 2,160 to 8,990/μL, Hb: 7.4 to 10.9 g/dL, platelets: 5.6 to 14.8×10 3 / μL). The bilateral abducens palsies and papilledema rapidly improved over the course of a week (Figure b ). The visual activity was well maintained (vision without correction: right: 0.4, left: 0.3; vision with correction: right: 1.5, left: 1.5) and the papilledema disappeared. The anti-dsDNA antibody titer, complement level, and proteinuria also gradually improved. The level of D-dimer promptly normalized (2.5 to 0.6 μg/mL), and there was no thrombotic tendency without anticoagulant therapy. Although the concomitant use of azathioprine for maintenance was discontinued due to the development of leukopenia in January 2011, remission was subsequently maintained with prednisolone at a dose of 3 mg/day for five years.
Discussion
IIH is defined by the modified Dandy criteria as follows: [1] symptoms and signs of increased intracranial pressure; [2] no localized neurologic signs, except for unilateral or bilateral 6th nerve palsies; [3] increased CSF opening pressure >200 mmH2O, but normal CSF composition; [4] no evidence of hydrocephalus, mass, structural, or vascular lesions on imaging; and [5] no other cause of increased intracranial pressure (ICP) identified (1) .
IIH is a rare disease in Japan compared to other countries. Yabe et al. reported that IIH occurred in only 0.03 per 100,000 people (two of 5,780,000 patients) in Hokkaido, compared with 0.9-1.1 per 100,000 people in the United States (5) . According to previous reports, the characteristics of IIH patients with SLE demonstrate several differences from other IIH patients. First, SLE patients have a higher prevalence of IIH than the general population. Hershko et al. reported that IIH occurred in 10 of 651 hospitalized SLE patients (prevalence, 1.5%) compared to 19 per 100,000 reported in the general population (6) . Second, obesity is a risk factor for IIH in the general population (7) ; however, Kim et al. reported that all eight SLE patients with IIH in their study had a normal body mass index (BMI <30 kg/ m 2 ) (8).
Corticosteroids and immunosuppressive agents were effective for the IIH in the present case. Most of the IIH in SLE cases can be treated using high-dose corticosteroids followed by immunosuppressants (6) , which differs from IIH cases in general, which are treated using acetazolamide or mannitol and weight loss. The pathophysiology of IIH may include the impairment of CSF absorption and venous outflow, rather than an increase in CSF production (9) . The pathogenesis of IIH in SLE patients is still unclear; however, some case reports showed that IIH develops in active SLE patients, and other previous reports suggested a possible relationship between anti-phospholipid antibodies (aPL) or antiphospholipid syndrome (APS) and IIH (6, 10) . Therefore, thrombosis and hypercoagulability may cause impaired CSF absorption and lead to IIH in patients with SLE. Some authors have proposed that it is better to perform MR venography in atypical cases (11) . In our case, we performed imaging studies using MRI, magnetic resonance angiography (MRA), and plain CT, in addition to common coagulation testing. However, evaluations for venous thrombosis and specific coagulation testing, such as the platelet aggregation activity, were not performed. Although we cannot fully exclude the possibility that venous thrombosis or hypercoagulation caused the IIH in the present case, the prompt improvement following the start of immunosuppressive therapy indicates that the IIH in the present case was induced not by a thrombotic mechanism, but instead by an inflammatory mechanism, most likely due to SLE. It is also known that anemia may cause IIH via an increase in the brain blood flow. Our case presented normocytic anemia due to SLE; however, the anemia in our case was mild, was unlikely to be the cause of the IIH, and recovered quickly.
Headache and vomiting are present in almost all IIH cases; however, the present case did not exhibit these symptoms. There have been reports in Japan of IIH that was incidentally diagnosed during a medical checkup or ophthalmology consultation without any clinical symptoms (12) (13) (14) . Although it is not clear what mechanisms are involved in the patients lacking symptoms, Simone et al. considered that genetic tolerance of a neurovascular headache may be associated with the lack of symptoms in some cases (15) . Aylward et al. reported that a younger age at onset and no obesity are related to a lack of a headache in children with IIH (16) . The present patient was young and not obese, so these characteristics might have been associated with her atypical symptoms of IIH. In SLE patients, cranial nerve palsies can also be caused by infection, vasculitis, thrombosis, or other central nervous system events. Therefore, the present case had to be carefully distinguished from cranial nerve palsy in the differential diagnosis.
In conclusion, we experienced a case of SLE with bilateral abducens nerve palsies due to IIH. The presence of IIH in SLE patients is rare, but this potential occurrence should not be overlooked.
